BPC-157, by contrast, modulates growth factor pathways (VEGF, FGF, NO system) involved in tissue repair without directly activating hormone receptors (Sikiric et al., J Physiol Pharmacol 2018)
Compounded semaglutide contains the same active ingredient but may include additional compounds that could slightly alter the GI experience
2018, doi: 10.1007/s00296-018-4142-x Chourpiliadis, C., et al, "Use of Common Psychiatric Medications and Risk and Prognosis of Amyotrophic Lateral Sclerosis," JAMA Network Open, June 4, 2024, doi:10.1001/jamanetworkopen.2025.14437 Meron, M.K., et al, "GLP-1 receptor agonists and the risk of fragility fractures in older adults with type 2 diabetes," Journal of Clinical Endocrinology & Metabolism, Feb.10, 2026, doi: 10.1210/clinem/dgag056 Luo, Y., et al, "GLP-1 receptor agonists in eye disease: a comprehensive review of current research and future potential," BMC Ophthalmology, Jan
Moreover, regulatory approvals for wider applications, including obesity and cardiovascular and renal diseases, open new therapeutic areas
Above 500mcg/mL, draw volumes drop below 10 units for most research protocols, where insulin syringe graduation marks become unreliable
One of those factors may be GLP-1
.webp)
